Search Results - "Guo, Yujiang"
-
1
Programmed Cell Death Protein-1 Predicts the Recurrence of Breast Cancer in Patients Subjected to Radiotherapy After Breast-Preserving Surgery
Published in Technology in cancer research & treatment (01-01-2018)“…Radiotherapy is the most important component of the comprehensive treatment of breast cancer, and immunocompromised patients respond with lower response rate…”
Get full text
Journal Article -
2
Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study
Published in Frontiers in oncology (16-07-2021)“…Background HER2-positive breast cancer was aggressive, resulting in a poorer prognosis. This multicenter study analyzed the real-world data of women treated…”
Get full text
Journal Article -
3
3D Printing of Cell‐Laden Microgel‐Based Biphasic Bioink with Heterogeneous Microenvironment for Biomedical Applications
Published in Advanced functional materials (01-03-2022)“…A major challenge in 3D extrusion bioprinting is the limited number of bioink that fulfills the opposing requirements for printability with requisite…”
Get full text
Journal Article -
4
The Job Burnout in College Teachers and the Management Strategy
Published in 2011 International Conference on Management and Service Science (01-08-2011)“…From the angle of Management Psychology, The survey discusses the correlations between job burnout in college teachers and their physical exercise by means of…”
Get full text
Conference Proceeding -
5
The inhibitory role of Mir-29 in growth of breast cancer cells
Published in Journal of experimental & clinical cancer research (01-12-2013)“…Mir-29 microRNA families are involved in regulation of various types of cancers. Although Mir-29 was shown to play an inhibitory role in tumorigenesis, the…”
Get full text
Journal Article -
6
Pyrotinib in the treatment of women with advanced HER2 positive breast cancer: A multicenter, prospective, real-world study
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e13012 Background: Pyrotinib is a newly-developed irreversible pan-ErbB receptor tyrosine kinase inhibitor. The efficacy of pyrotinib in patients…”
Get full text
Journal Article -
7
Abstract PS10-43: Pyrotinib in the treatment of women with advanced HER2 positive breast cancer: A multicenter, prospective, real world study
Published in Cancer research (Chicago, Ill.) (15-02-2021)“…Abstract Backgrounds: Pyrotinib (an irreversible pan-ErbB receptor tyrosine kinase inhibitor) plus capecitabine have been approved for patients with advanced…”
Get full text
Journal Article -
8
Light-controlled synthesis of uniform platinum nano- dendrites with markedly enhanced electrocatalytic activity
Published in 纳米研究:英文版 (2013)“…We report a fast in situ seeding approach based on zinc(II) porphyrin (ZnP) under white light irradiation, leading to uniform spherical platinum nanodendrites…”
Get full text
Journal Article